Human Fetal Liver: An In Vitro Model of Erythropoiesis

We previously described the large-scale production of RBCs from hematopoietic stem cells (HSCs) of diverse sources. Our present efforts are focused to produce RBCs thanks to an unlimited source of stem cells. Human embryonic stem (ES) cells or induced pluripotent stem cell (iPS) are the natural cand...

Full description

Saved in:
Bibliographic Details
Main Authors: Guillaume Pourcher, Christelle Mazurier, Yé Yong King, Marie-Catherine Giarratana, Ladan Kobari, Daniela Boehm, Luc Douay, Hélène Lapillonne
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.4061/2011/405429
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832555563102240768
author Guillaume Pourcher
Christelle Mazurier
Yé Yong King
Marie-Catherine Giarratana
Ladan Kobari
Daniela Boehm
Luc Douay
Hélène Lapillonne
author_facet Guillaume Pourcher
Christelle Mazurier
Yé Yong King
Marie-Catherine Giarratana
Ladan Kobari
Daniela Boehm
Luc Douay
Hélène Lapillonne
author_sort Guillaume Pourcher
collection DOAJ
description We previously described the large-scale production of RBCs from hematopoietic stem cells (HSCs) of diverse sources. Our present efforts are focused to produce RBCs thanks to an unlimited source of stem cells. Human embryonic stem (ES) cells or induced pluripotent stem cell (iPS) are the natural candidates. Even if the proof of RBCs production from these sources has been done, their amplification ability is to date not sufficient for a transfusion application. In this work, our protocol of RBC production was applied to HSC isolated from fetal liver (FL) as an intermediate source between embryonic and adult stem cells. We studied the erythroid potential of FL-derived CD34+ cells. In this in vitro model, maturation that is enucleation reaches a lower level compared to adult sources as observed for embryonic or iP, but, interestingly, they (i) displayed a dramatic in vitro expansion (100-fold more when compared to CB CD34+) and (ii) 100% cloning efficiency in hematopoietic progenitor assays after 3 days of erythroid induction, as compared to 10–15% cloning efficiency for adult CD34+ cells. This work supports the idea that FL remains a model of study and is not a candidate for ex vivo RBCS production for blood transfusion as a direct source of stem cells but could be helpful to understand and enhance proliferation abilities for primitive cells such as ES cells or iPS.
format Article
id doaj-art-c594291bd99e4bcbb45125212547a76b
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-c594291bd99e4bcbb45125212547a76b2025-02-03T05:47:58ZengWileyStem Cells International1687-966X1687-96782011-01-01201110.4061/2011/405429405429Human Fetal Liver: An In Vitro Model of ErythropoiesisGuillaume Pourcher0Christelle Mazurier1Yé Yong King2Marie-Catherine Giarratana3Ladan Kobari4Daniela Boehm5Luc Douay6Hélène Lapillonne7Prolifération et Différenciation des Cellules Souches: Application à la Thérapie Cellulaire Hématopoïétique, INSERM, UMR_S938, CDR Saint-Antoine, 75012 Paris, FranceProlifération et Différenciation des Cellules Souches: Application à la Thérapie Cellulaire Hématopoïétique, INSERM, UMR_S938, CDR Saint-Antoine, 75012 Paris, FranceProlifération et Différenciation des Cellules Souches: Application à la Thérapie Cellulaire Hématopoïétique, INSERM, UMR_S938, CDR Saint-Antoine, 75012 Paris, FranceProlifération et Différenciation des Cellules Souches: Application à la Thérapie Cellulaire Hématopoïétique, INSERM, UMR_S938, CDR Saint-Antoine, 75012 Paris, FranceProlifération et Différenciation des Cellules Souches: Application à la Thérapie Cellulaire Hématopoïétique, INSERM, UMR_S938, CDR Saint-Antoine, 75012 Paris, FranceProlifération et Différenciation des Cellules Souches: Application à la Thérapie Cellulaire Hématopoïétique, INSERM, UMR_S938, CDR Saint-Antoine, 75012 Paris, FranceProlifération et Différenciation des Cellules Souches: Application à la Thérapie Cellulaire Hématopoïétique, INSERM, UMR_S938, CDR Saint-Antoine, 75012 Paris, FranceProlifération et Différenciation des Cellules Souches: Application à la Thérapie Cellulaire Hématopoïétique, INSERM, UMR_S938, CDR Saint-Antoine, 75012 Paris, FranceWe previously described the large-scale production of RBCs from hematopoietic stem cells (HSCs) of diverse sources. Our present efforts are focused to produce RBCs thanks to an unlimited source of stem cells. Human embryonic stem (ES) cells or induced pluripotent stem cell (iPS) are the natural candidates. Even if the proof of RBCs production from these sources has been done, their amplification ability is to date not sufficient for a transfusion application. In this work, our protocol of RBC production was applied to HSC isolated from fetal liver (FL) as an intermediate source between embryonic and adult stem cells. We studied the erythroid potential of FL-derived CD34+ cells. In this in vitro model, maturation that is enucleation reaches a lower level compared to adult sources as observed for embryonic or iP, but, interestingly, they (i) displayed a dramatic in vitro expansion (100-fold more when compared to CB CD34+) and (ii) 100% cloning efficiency in hematopoietic progenitor assays after 3 days of erythroid induction, as compared to 10–15% cloning efficiency for adult CD34+ cells. This work supports the idea that FL remains a model of study and is not a candidate for ex vivo RBCS production for blood transfusion as a direct source of stem cells but could be helpful to understand and enhance proliferation abilities for primitive cells such as ES cells or iPS.http://dx.doi.org/10.4061/2011/405429
spellingShingle Guillaume Pourcher
Christelle Mazurier
Yé Yong King
Marie-Catherine Giarratana
Ladan Kobari
Daniela Boehm
Luc Douay
Hélène Lapillonne
Human Fetal Liver: An In Vitro Model of Erythropoiesis
Stem Cells International
title Human Fetal Liver: An In Vitro Model of Erythropoiesis
title_full Human Fetal Liver: An In Vitro Model of Erythropoiesis
title_fullStr Human Fetal Liver: An In Vitro Model of Erythropoiesis
title_full_unstemmed Human Fetal Liver: An In Vitro Model of Erythropoiesis
title_short Human Fetal Liver: An In Vitro Model of Erythropoiesis
title_sort human fetal liver an in vitro model of erythropoiesis
url http://dx.doi.org/10.4061/2011/405429
work_keys_str_mv AT guillaumepourcher humanfetalliveraninvitromodeloferythropoiesis
AT christellemazurier humanfetalliveraninvitromodeloferythropoiesis
AT yeyongking humanfetalliveraninvitromodeloferythropoiesis
AT mariecatherinegiarratana humanfetalliveraninvitromodeloferythropoiesis
AT ladankobari humanfetalliveraninvitromodeloferythropoiesis
AT danielaboehm humanfetalliveraninvitromodeloferythropoiesis
AT lucdouay humanfetalliveraninvitromodeloferythropoiesis
AT helenelapillonne humanfetalliveraninvitromodeloferythropoiesis